Glucose Monitoring After Acute Myocardial Infarct in People With Diabetes

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 160 participants.

Also called NCT05431296

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 160 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05431296
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United Kingdom (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT05431296. Randomized; no masking; primary purpose treatment. Start 2023-02-07 (actual); primary completion 2024-08 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Glucose Monitoring After Acute Myocardial Infarct in People With Diabetes
Acronym
GLAM
Condition
Acute Myocardial Infarction
Condition
Acute Myocardial Infarction With ST Elevation
Condition
Diabetes Complications
Intervention (Device)
Dexcom ONE Continuous Glucose Monitoring System
Lead sponsor
Imperial College London (class: other)

Record details

Record id
cardio:ct-nct05431296
Content hash
c0b02dd932f1a477e4f40768a562703f2b08e6766a02f8518754a2aaecfc2a6e